In a previous report, cell viability curves were compared between temozolomide, camptothecin, and cisplatin in DT40 cells (chicken lymphoma cell line) and DU145 cells (prostate cancer cell line), and PARP inhibitor just added its own cytotoxicity [16]. Here, PARP1 is linked to prostate cancer.